Prior Authorization in 2027: WISeR, CMS-0057-F, MIPS

Three separate federal changes are being discussed as “prior authorization in 2027,” and they do not apply to the same patients or the same people in your practice. WISeR is a CMS model that has applied prior authorization or pre-payment review to 13 service categories in six states (Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington) for Original Medicare patients since January 2026. CMS-0057-F requires payers, not practices, to have working Prior Authorization APIs beginning January 1, 2027. And the MIPS Electronic Prior Authorization measure is optional in 2027, not required, worth 10 bonus points, and becomes required in CY 2028.

The honest summary for a front desk or billing lead is that the only new hard date on January 1, 2027 falls on the payer side. For most practices the day-one workflow stays the same portals, faxes, and phone calls, with a handful of things worth doing now. None of the 13 WISeR categories is outpatient physical therapy, occupational therapy, speech-language pathology, or chiropractic manipulation (our reading of the guide’s service tables), but a surgeon’s or pain physician’s WISeR request can turn on the therapy record. This guide works from CMS’s own materials: the WISeR Provider and Supplier Operational Guide, version 7.0, the CMS-0057-F fact sheet, and the CY 2027 Physician Fee Schedule final rule published November 9, 2026. Current as of November 2026.

What actually changes for prior authorization on January 1, 2027?

What Who it applies to Date Status as of November 2026
WISeR model continues (second performance year) Original Medicare patients in AZ, NJ, OH, OK, TX, WA, for 13 service categories Launched January 1, 2026, for services on or after January 15, 2026; runs through December 31, 2031 In effect, no added states or services announced
Prior Authorization API, Provider Access API, Payer-to-Payer API Impacted payers (Medicare Advantage, Medicaid and CHIP, exchange plans), not practices January 1, 2027 for MA and state Medicaid and CHIP fee-for-service; later for other payer types Final, date unchanged
Payer APIs conform to named implementation guides Impacted payers Proposed October 1, 2027 Proposed, not final
MIPS Electronic Prior Authorization measure MIPS eligible clinicians CY 2027 optional; CY 2028 required Final
Prior authorization for two upper limb orthoses (DMEPOS) Original Medicare, phased by state January 26, 2027 and April 26, 2027 Scheduled, per CMS’s page as revised September 1, 2026

WISeR is not new in 2027. CMS’s model page, last modified October 19, 2026, still lists six participants and six states and announces no additional states.

Which states and services are in the WISeR model?

WISeR “will run for six performance years from January 1, 2026 to December 31, 2031 in six states: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington,” according to the CMS model page. The operational guide (§1.4) says the six states sit across four MAC jurisdictions. Requests submitted on or after January 5, 2026 apply to services rendered on or after January 15, 2026.

State MAC jurisdiction WISeR participant (as CMS lists it)
Arizona JF Noridian Zyter Inc.
New Jersey JL Novitas Genzeon Corporation
Ohio J15 CGS Innovaccer Inc.
Oklahoma JH Novitas Humata Health, Inc.
Texas JH Novitas Cohere Health, Inc.
Washington JF Noridian Virtix Health LLC

The guide’s quick reference reduces the question of whether you are affected to two tests. Does the provider practice in Arizona, New Jersey, Ohio, Oklahoma, Texas, or Washington? And will the provider deliver at least one of the listed select items and services to Original Medicare beneficiaries? If either answer is no, WISeR does not apply to that patient.

Does WISeR apply to Medicare Advantage?

No. The model page says “WISeR does not apply to people with Medicare Advantage and will have no impact on them.” The guide adds that Railroad Medicare beneficiaries are not impacted, and that providers under review by a Unified Program Integrity Contractor (UPIC) are excluded (§1.2).

What are the 13 WISeR service categories?

Appendix A of the guide, titled “WISeR Select Items and Services as of July 24, 2026,” has 13 tables, A1 to A13.

# Service category Coverage policy
1 Arthroscopic lavage and arthroscopic debridement for the osteoarthritic knee NCD 150.9
2 Induced lesions of nerve tracts NCD 160.1
3 Vagus nerve stimulation NCD 160.18
4 Phrenic nerve stimulators NCD 160.19
5 Electrical nerve stimulators NCD 160.7
6 Incontinence control devices NCD 230.10
7 Sacral nerve stimulation for urinary incontinence NCD 230.18
8 Diagnosis and treatment of impotence NCD 230.4
9 Percutaneous vertebral augmentation for vertebral compression fracture LCDs L34228, L38201, L35130
10 Epidural steroid injections for pain management LCDs L39015, L39240, L36920
11 Cervical fusion LCDs L39741, L39758, L39793
12 Hypoglossal nerve stimulation for obstructive sleep apnea LCDs L38307, L38310, L38385
13 Skin substitutes for lower extremity chronic non-healing wounds LCDs L35041, L36690

Categories 1 to 12 apply in all six states. Skin substitutes are the exception. The WISeR FAQ (last modified September 22, 2026) says states with an active skin substitute LCD include them, and states without one do not. Confirm with your MAC which applies to you.

Which two services are listed but delayed?

The guide lists 15 services in Section 6. Two are delayed, not active: deep brain stimulation (NCD 160.24) and percutaneous image-guided lumbar decompression for spinal stenosis (NCD 150.13). Both are “to be reevaluated for implementation in a future performance year” (§6.1 to 6.2). As of guide version 7.0 (July 24, 2026), neither has been activated.

Which sites of service are included?

Per the guide (§1.5), the sites are hospital outpatient department (TOB 13X for facility claims, corresponding to POS 19 and 22 on professional claims), ambulatory surgery center (POS 24), home (POS 12), and office (POS 11). In the OPD and ASC settings, WISeR selects facility-based encounters and claims, not professional services. The FAQ says professional encounters and claims are subject to prior authorization and pre-payment review for services delivered in the office or home in selected states.

Can the list change?

Yes. The guide says CMS “may update the WISeR Select Items and Services list during the WISeR Model’s performance period” and that changes would be communicated to providers. The guide had seven versions between October 10, 2025 and July 24, 2026, so always work from the current one. WISeR does not change Medicare coverage or payment policy, according to the model page, and the FAQ says it does not change payment rates for the included items or services.

Does WISeR require prior authorization for physical therapy or chiropractic care?

No, based on our reading of Appendix A, Tables A1 to A13, of guide version 7.0. The tables contain no physical therapy, occupational therapy, speech-language pathology, or chiropractic manipulation codes. Nor, in our reading, does any program on CMS’s list of Original Medicare prior authorization and pre-claim review initiatives cover outpatient therapy, as of November 2026. Our Medicare Advantage outpatient therapy rules post covers how that differs from Medicare Advantage.

Therapy still shows up inside WISeR requests. The therapist is not the one requesting authorization, but the therapist’s notes can be part of the package the requesting physician sends.

Where do therapy records enter a WISeR request?

For epidural steroid injections (§6.2.10), the required documentation includes:

The same section requires that an objective pain scale or functional assessment was performed at baseline, before interventions, and that the same scale was repeated at each follow-up. For spinal cord stimulator implantation under NCD 160.7 (§6.2.5), documentation includes at least one treatment tried and failed, or documentation that it was contraindicated, from a list that includes physical therapy.

A therapy record that shows dates of care, a baseline and repeated functional measure, and a home exercise program is the kind of record those sections describe. That is our reading of the guide, not a statement that CMS reviews therapy under WISeR.

What does the knee arthroscopy request need?

Table A1 lists one code: 29877, arthroscopy of the knee with debridement or shaving of articular cartilage (chondroplasty). Under §6.2.1 the documentation includes that the patient has less severe or early degenerative arthritis and is presenting with symptoms other than pain alone, “e.g., mechanical symptoms that include, but are not limited to, catching, locking, snapping, or popping.” It also includes documentation supporting the knee condition, including reports of standing x-rays, MRI results, and, in the event of pre-payment review, arthroscopy results.

Which other orthopedic and spine codes are listed?

Category Codes in Appendix A Note
Percutaneous vertebral augmentation (Table A9) 22510, 22511, 22512 (vertebroplasty); 22513, 22514, 22515 (vertebral augmentation, e.g., kyphoplasty)
Epidural steroid injections (Table A10) 62321, 62323, 64479, 64480, 64483, 64484 CPT 62323 does not require prior authorization or pre-payment review under WISeR when submitted for indications other than those specified in the selected LCDs
Cervical fusion (Table A11) 22554 CPT 22551 and 22552 are included in CMS’s hospital outpatient department prior authorization program instead

How does a WISeR prior authorization request work?

Is WISeR prior authorization mandatory?

Submitting a request is voluntary, but skipping it has a consequence. The guide (§7.2) says that if a claim for a select item or service is submitted without a prior authorization decision on file, “the MAC will suspend the related claim and re-route it to the WISeR Participant to conduct pre-payment medical review.” So the real choice is between prior authorization before the service and pre-payment review after it.

Prior authorization Pre-payment review
When Before the service After the claim is submitted
Decision clock 3 calendar days, 2 for expedited requests 45 days for the provider to respond to the ADR; 3 days for the participant to decide after receiving all documentation
If you miss it A non-affirmation, with unlimited resubmissions If the provider does not respond to the ADR within 45 days, the MAC denies the related claim
Who gets the ADR Not applicable For OPDs and ASCs, the billing facility, not the physician or practitioner

How do you submit, and how long does it take?

Requests go “directly to the WISeR Participant in their state or to their regularly assigned Medicare Administrative Contractor (MAC),” by mail, fax, Electronic Submission of Medical Documentation (esMD), or the electronic portal. Participants plan to issue a determination within 3 calendar days of receiving the initial or resubmitted request, and expedited requests within 2 calendar days (guide quick reference). Expedited review applies if delays “could seriously jeopardize the WISeR Beneficiary’s life, health, or ability to regain maximum function” (§4.2.2). Requests sent to a MAC or by mail can take longer, according to the FAQ.

What does the request contain?

Per the FAQ, a completed cover sheet or designated request form plus:

How long is an affirmation valid?

The Unique Tracking Number (UTN) is valid for 120 calendar days from the decision date (§4.3). CMS’s example: a request affirmed January 5, 2026 is valid for dates of service through May 4, 2026. The UTN goes on the claim, so the biller needs it and its end date.

What happens after a non-affirmation?

The guide’s quick reference says there is no limit to the number of resubmissions, and a resubmission carries the opportunity to request peer-to-peer clinical review. The FAQ says a human clinician with relevant clinical expertise must review every non-affirmation. A non-affirmed decision does not prevent the provider from delivering the service and submitting a claim. The MAC’s denial of that claim is an initial payment determination subject to existing administrative appeals.

If payment is expected to be denied, the guide (§8.1) says the provider should issue an Advance Beneficiary Notice of Non-Coverage (ABN) before performing the service and submit the claim with the GA modifier. Our ABN and GA modifier guide covers the mechanics.

Do associated codes matter?

Yes. Per the FAQ, claims for associated codes are denied or recouped if a primary code has a non-affirmed prior authorization or is denied in pre-payment review. Associated codes do not need separate prior authorization, and Appendix C of the guide lists them. The FAQ also says professional claims can later be flagged through the associated code list when a facility claim is non-affirmed or denied. In practice, a surgeon’s professional claim can be affected by the facility’s WISeR outcome.

What is the WISeR exemption program?

Beginning in July 2026, CMS and the participants began automatically exempting individual providers from prior authorization and pre-payment review once they demonstrate compliance (guide §5). Exemption is granted at the individual NPI level, not the facility or organization level. To qualify, a provider must submit at least 10 prior authorization requests across the select items and services during an assessment period and reach a minimum affirmation rate threshold. The guide does not publish the percentage; participant-specific criteria are posted by the participants.

Providers are added to the exemption list quarterly and keep status for at least a year, or longer at the participant’s discretion. Reevaluation uses no more than 10 additional documentation requests per year (§5.2). A provider who always skips prior authorization and takes pre-payment review never accumulates the 10 requests.

On claims, the exempted NPI goes in the rendering provider field for office and home, the referring or ordering provider field in an ASC, and the operating provider field in an outpatient department (§5.1).

What other Original Medicare prior authorization applies to an orthopedic practice?

WISeR is built not to overlap. The guide (§1.5) says it excludes codes already subject to prior authorization under existing CMS programs. CMS’s list of initiatives currently in place includes the hospital outpatient department list, repetitive scheduled non-emergent ambulance transport, DMEPOS items, and two Review Choice Demonstrations. None of them is an outpatient therapy program, in our reading of that list as of November 2026.

Program What matters to an orthopedic practice Dates and timeframes
Hospital OPD services, nationwide Includes implanted spinal neurostimulators and cervical fusion with disc removal (from July 1, 2021) and facet joint interventions (from July 1, 2023) Standard decisions in 7 calendar days for requests on or after January 1, 2025; expedited in 2 business days (page last modified November 6, 2026)
DMEPOS orthoses Four orthoses codes, one PRSS, and one manual wheelchair base nationwide from October 28, 2026; certain lower limb orthoses and lumbar sacral orthoses nationwide since August 12, 2024 Two upper limb orthoses in three phases: October 28, 2026 in CA, FL, MI, NY; January 26, 2027 adds AZ, GA, IL, MA, OH, OR, PA, TX; April 26, 2027 nationwide

The DMEPOS page names the newly selected orthoses codes: thoracic lumbar sacral orthoses L0456, L0457, and L0486 and knee orthosis L1833 (nationwide from October 28, 2026), and upper limb orthoses L3761 and L3916 (the three phases above). The complete list is in the Required Prior Authorization List PDF the page links, so check it if you dispense orthoses. The Review Choice Demonstration that CMS is extending to California for billing periods beginning on or after January 18, 2027 is a program for home health agencies, not for outpatient therapy, and CMS says its implementation depends on a pending paperwork approval (CMS RCD page, as of November 2026).

What does CMS-0057-F require on January 1, 2027, and from whom?

Which payers does CMS-0057-F cover?

The fact sheet names the impacted payers: Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan (QHP) issuers on the Federally Facilitated Exchanges.

Three things are outside it:

What has already been in force since January 1, 2026?

Requirement Detail Source
Decision timeframes 72 hours expedited, 7 calendar days standard, for impacted payers excluding QHP issuers on the FFEs Fact sheet; for MA, 42 CFR 422.568(b)(1)(ii)
Specific denial reason Required “regardless of the method used to send the prior authorization request,” whether communicated by portal, fax, email, mail, or phone Fact sheet; for MA, 42 CFR 422.122(a)
Public metrics Initial set reported by March 31, 2026. MA organizations post, at the contract level, a list of all items and services requiring prior authorization, approval and denial percentages, the percentage approved after appeal, and average and median time to a determination Fact sheet; 42 CFR 422.122(c)

Our Medicare Advantage outpatient therapy rules post has the full MA timeframe table, so we do not repeat it here. For one plan’s program, see our UnitedHealthcare prior authorization guide.

What is new on January 1, 2027?

Four APIs. As the fact sheet describes them:

What are the compliance dates by payer type?

The November 9, 2026 final rule restates them (91 FR 71570).

Payer type Compliance date
Medicare Advantage organizations January 1, 2027
State Medicaid and CHIP fee-for-service programs January 1, 2027
Medicaid managed care plans and CHIP managed care entities By the first rating period beginning on or after January 1, 2027
Individual market QHP issuers on the FFEs For plan years beginning on or after January 1, 2027

The same rule confirms the date stands: “impacted payers must still implement Prior Authorization APIs beginning in CY 2027.”

Is there a later standards date?

Proposed, not final, as of November 2026. In the April 14, 2026 proposed rule (91 FR 19890), CMS proposed that payer APIs conform to the CRD, DTR, and PAS implementation guides, with compliance dates beginning October 1, 2027. The 2024 rule only recommended, rather than required, specific FHIR implementation guides. CRD is Coverage Requirements Discovery, DTR is Documentation Templates and Rules, and PAS is Prior Authorization Support. The same proposal would require impacted payers to support electronic prior authorization for all drugs that require it, beginning October 1, 2027. CMS describes both as part of a proposed rule in the November 9 final rule (91 FR 71570).

What changes at the front desk versus what is payer plumbing?

No provision of CMS-0057-F requires a practice to submit through an API on January 1, 2027. The obligations fall on payers. The denial-reason requirement applies “regardless of the method used to send the prior authorization request.” In our reading, the Medicare Advantage decision timeframe in 42 CFR 422.568(b)(1) also does not depend on the channel: it runs from when the plan receives the request.

Requirement Who must do it What the practice sees
Prior Authorization API live (January 1, 2027 for MA; dates above for others) Impacted payer Nothing, unless your EHR or another certified tool connects to it
List of items and services needing authorization, and documentation rules, available through the API Impacted payer Potentially an in-workflow answer to whether something needs authorization and what the payer wants; until connected, the payer’s portal and posted list
Decision in 7 calendar days standard, 72 hours expedited (not QHP issuers on the FFEs) Impacted payer, since January 1, 2026 A clock you can hold the plan to
Specific denial reason Impacted payer, since 2026 A reason you can act on in a resubmission or appeal
Annual public metrics by March 31 Impacted payer The plan’s approval, denial, and turnaround numbers on its website
Provider Access API Impacted payer, by January 1, 2027 For in-network providers, claims, clinical data, and prior authorization information for attributed patients, if your software connects
Payer-to-Payer API Impacted payer, by January 1, 2027 A new plan may already hold the patient’s prior authorization history (opt-in by the patient)

What should you ask your software vendors?

A practice can only use a payer’s Prior Authorization API through software. CMS’s electronic prior authorization page (last modified November 10, 2026) says “Talk to your EHR vendor to confirm readiness” and suggests asking:

CMS acknowledges that electronic prior authorization workflows often involve multiple systems, including EHRs, revenue cycle systems, payer systems, clearinghouses, health information exchanges, and standards-based intermediaries (91 FR 71572). Ask your clearinghouse or revenue cycle vendor the same questions, including whether its product is certified to 45 CFR 170.315(g)(31), (32), or (33). CMS also expects uneven readiness. It says achieving widespread implementation in CY 2027 “may be challenging, particularly for small, rural, and otherwise under-resourced MIPS eligible clinicians” (91 FR 71578 to 71579).

The fact sheet also says HHS will use enforcement discretion for covered entities that implement an all-FHIR-based Prior Authorization API without the X12 278 standard, and that covered entities may still offer an X12-only transaction.

Is the MIPS Electronic Prior Authorization measure required in 2027?

No. The 2024 rule added the measure to the Health Information Exchange objective of the MIPS Promoting Interoperability category, to be reported beginning with the CY 2027 performance period. As originally finalized, a “No” or missing response meant a score of zero for Promoting Interoperability, weighted at 25 percent of the MIPS final score. The CY 2027 Physician Fee Schedule final rule (CMS-1848-F, 91 FR 70992) changed that: “we are finalizing, as proposed, the proposal to modify the Electronic Prior Authorization measure to be an optional measure and eligible for 10 bonus points for the CY 2027 performance period/2029 MIPS payment year” (91 FR 71580).

Under the optional policy, a clinician who submits a “No” would not have an affected Promoting Interoperability score (91 FR 71579). Exclusions are not offered for CY 2027 because there are no negative consequences for not reporting.

Performance period Payment year Status of the measure Source
CY 2027 2029 Optional; 10 bonus points for “Yes”; “No” does not affect the score; no exclusions needed 91 FR 71580
CY 2028 and later 2030 and later Required; “Yes” or an exclusion; otherwise zero for Promoting Interoperability 91 FR 71580 to 71582

What counts as a “Yes” in CY 2027?

The measure reads: “For at least one medical item or service (excluding drugs) ordered by the MIPS eligible clinician during the performance period, the prior authorization is requested electronically through a Prior Authorization API using CEHRT.” Per 91 FR 71572:

What changes in CY 2028?

CMS finalized, as proposed, a requirement to report the measure beginning with the CY 2028 performance period (91 FR 71582). The clinician must use CEHRT to request and receive coverage requirements, populate documentation using templates and rules, submit the request, and receive the payer response through a Prior Authorization API, for at least one medical item or service (excluding drugs), with CEHRT certified to all three criteria. A “No,” no attestation, or no exclusion means a score of zero for Promoting Interoperability, weighted at 25 percent of the MIPS final score (91 FR 71580 to 71581). A separate required measure, Electronic Prior Authorization for Prescription Drugs, also starts with the CY 2028 performance period (91 FR 71510).

CY 2028 has two exclusions. A clinician is excluded who does not order any medical items or services (excluding drugs) requiring prior authorization during the performance period, or who only orders such items or services from a payer that does not offer an API meeting CMS’s requirements. If a clinician cannot use CEHRT to exchange information and submit a request with any payer they seek authorization from, CMS says that would be sufficient to claim the payer lacks a functioning API (91 FR 71581).

Whether your therapy practice must report MIPS at all, and how Promoting Interoperability works for small practices, is covered in our MIPS for therapy practices guide.

Prior authorization checklist by payer type

Question Original Medicare Medicare Advantage Commercial and employer plans
Is outpatient PT, OT, or SLP subject to federal prior authorization? No program on CMS’s list of initiatives covers it Plan-specific; see our MA and UnitedHealthcare posts Plan-specific; see our commercial visit limits post
Does WISeR apply? Yes, only in AZ, NJ, OH, OK, TX, WA and only for the 13 categories No No
Other federal programs Hospital OPD list; DMEPOS required list for certain orthoses Not applicable; plan rules Not applicable; plan rules
Decision clock WISeR: 3 calendar days, 2 expedited. OPD: 7 calendar days, 2 business days expedited 7 calendar days standard, 72 hours expedited Not set by CMS-0057-F; QHP issuers on the FFEs are excluded from the decision timeframes, so check plan and state rules
Prior Authorization API required January 1, 2027? No, not directly Yes Only QHP issuers on the FFEs, for plan years beginning on or after January 1, 2027; other commercial plans voluntary
Specific denial reason required? Not under CMS-0057-F; a WISeR non-affirmation comes with a detailed decision notification Yes, since January 1, 2026 Only impacted payers

What should you check for each patient?

  1. Identify the coverage type from the card and eligibility response: Original Medicare, Medicare Advantage (and which plan), Medicaid, exchange plan, or employer plan. WISeR applies only to Original Medicare, and Railroad Medicare is outside it. The hospital OPD and DMEPOS programs sit on CMS’s list of Medicare fee-for-service compliance programs and run through the MACs.
  2. For Original Medicare in AZ, NJ, OH, OK, TX, or WA, check the procedure code against Appendix A of the current WISeR guide. If it is listed, decide between prior authorization and pre-payment review before scheduling, and remember an affirmation is valid 120 calendar days.
  3. If the service is in a hospital outpatient department, check the OPD list as well. Codes on that list go through the MAC under that program, not WISeR.
  4. If the practice dispenses orthoses, check the DMEPOS Required Prior Authorization List and the January 26, 2027 and April 26, 2027 phase dates.
  5. For a WISeR epidural steroid injection or stimulator request, pull the therapy record: conservative care dates, the baseline and repeated pain or functional scale, and the home exercise program.
  6. For Medicare Advantage, use the plan’s own list and tool, hold the plan to 7 calendar days and 72 hours, and expect a specific reason if it denies. See our UnitedHealthcare prior authorization guide.
  7. For commercial plans, the federal clocks generally do not apply. Verify plan rules and visit thresholds in our commercial payer visit limits guide. After a denial, see commercial therapy claim denials and appeals.
  8. Record the authorization or tracking number and its end date where the biller will see it at claim time (the UTN on WISeR claims).

What to re-check and when


A WISeR request for an injection or stimulator can turn on the conservative-care record, and that record is easier to send when the surgeon’s and the therapist’s documentation live in one chart. PrismEHR is a multi-specialty EHR for PT, chiropractic, orthopedic, wellness, and primary care practices, and for orthopedic practices with in-house PT it gives orthopedic and PT providers one patient record, with specialty-specific views and compliance checks at documentation time. For the Medicare Advantage side of the picture, see our outpatient therapy rules guide.